「fortherepublic of kiribati」の検索結果
138件：56～60件目を表示
-
OTC Products, etc. | Products | SENJU Pharmaceutical
d from the Japanese package insert. Products Sort by Efficacy Sort by Efficacy Eyestrain Prevention of dry-eyes Redness of the conjunctiva Conjunctival hyperemia Itchy eyes Blurred vision (eye mucus) ...
http://www.senju.co.jp/english/products/clg.html -
千寿製薬株式会社
acturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibiti...
http://www.senju.co.jp/english/ -
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and licensed to Senju as...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and licensed to Senju as...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf